Ethiopia Antimalarial in Vivo Efficacy Study 2012

NCT01680406 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

398

Enrollment

FED

Sponsor class

Conditions

Plasmodium Vivax Infection

Interventions

DRUG: Artemether-lumefantrine combination
DRUG: Primaquine
DRUG: Chloroquine

Sponsor

Centers for Disease Control and Prevention

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]